Reported 3 shares, unchanged from the prior quarter.
Reported value -25.0%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 9000 |
| 2021-12-31 | 8000 |
| 2022-03-31 | 7000 |
| 2022-06-30 | 0 |
| 2023-12-31 | 25 |
| 2024-03-31 | 11 |
| 2024-06-30 | 16 |
| 2024-09-30 | 24 |
| 2024-12-31 | 7 |
| 2025-03-31 | 7 |
| 2025-06-30 | 4 |
| 2025-09-30 | 3 |
| 2025-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2025 | Reduced | 0 | -3 (-100.0%) | 0 | $0 | 2026-02-13 | |
| Q3 2025 | Unchanged | 3 | 0 (0.0%) | < 0.01% | $3 | 2025-11-14 | |
| Q2 2025 | Reduced | 3 | -3 (-50.0%) | < 0.01% | $4 | 2025-08-15 | |
| Q1 2025 | Unchanged | 6 | 0 (0.0%) | < 0.01% | $7 | 2025-05-15 | |
| Q4 2024 | Reduced | 6 | -2 (-25.0%) | < 0.01% | $7 | 2025-02-14 | |
| Q3 2024 | Added | 8 | +2 (33.3%) | < 0.01% | $24 | 2024-11-14 | |
| Q2 2024 | Unchanged | 6 | 0 (0.0%) | < 0.01% | $16 | 2024-08-14 | |
| Q1 2024 | Reduced | 6 | -2 (-25.0%) | < 0.01% | $11 | 2024-05-15 | |
| Q4 2023 | New | 8 | +8 (0.0%) | < 0.01% | $25 | 2024-02-13 | |
| Q2 2022 | Reduced | 0 | -5,539 (-100.0%) | 0 | $0 | 2022-08-15 | |
| Q1 2022 | Unchanged | 5,539 | 0 (0.0%) | < 0.01% | $7,000 | 2022-05-13 | |
| Q4 2021 | Unchanged | 5,539 | 0 (0.0%) | < 0.01% | $8,000 | 2022-02-14 | |
| Q3 2021 | Reduced | 5,539 | -690 (-11.1%) | < 0.01% | $9,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
18 managers reported AKARI THERAPEUTICS PLC for Q3 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Cresset Asset Management LLC | Added | 822,468 | +804,060 | < 0.01% | $830,693 | 6 qtrs |
| Palo Alto Investors LP | Unchanged | 146,024 | 0 | 0.03% | $147,484 | 4 qtrs |
| HighTower Advisors LLC | Unchanged | 79,236 | 0 | < 0.01% | $80,028 | 2 qtrs |
| Omnia Family Wealth LLC | Reduced | 28,440 | -34,250 | < 0.01% | $28,724 | 9 qtrs |
| Cerity Partners LLC | Unchanged | 23,643 | 0 | < 0.01% | $23,879 | 9 qtrs |
| Virtu Financial LLC | New | 22,502 | +22,502 | < 0.01% | $22,000 | 1 qtr |
| TWO SIGMA SECURITIES LLC | New | 19,753 | +19,753 | < 0.01% | $19,951 | 1 qtr |
| Independent Advisor Alliance | New | 10,887 | +10,887 | < 0.01% | $10,996 | 1 qtr |
| Accent Capital Management LLC | Unchanged | 10,000 | 0 | < 0.01% | $10,100 | 4 qtrs |
| NewEdge Advisors LLC | Unchanged | 6,800 | 0 | < 0.01% | $6,868 | 2 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2025
- Filed
- November 14, 2025
- Filing type
- 13F-HR
- Position type
- SPONSORED ADR
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 3
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.